Macquarie tips almost 20% return for this ASX All Ords stock

Let's see what the broker is recommending to clients.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be close to a record high, but that doesn't mean there aren't big potential returns out there for investors.

For example, listed below is one ASX All Ords stock that Macquarie Group Ltd (ASX: MQG) believes could deliver big returns over the next 12 months.

A young man wearing a black and white striped t-shirt looks surprised.

Image source: Getty Images

Which ASX All Ords stock?

The stock that is getting a big thumbs up from Macquarie is Propel Funeral Partners Ltd (ASX: PFP).

As you might have guessed from its name, it is a funerals company that owns and operates funeral homes, cemeteries, and crematoria.

Macquarie was pleased with the company's "solid" performance in FY 2025 and its strong start to the new financial year. In respect to its results, the broker highlights that the ASX All Ords stock outperformed its guidance. It said:

FY25 result slightly ahead of guidance. Revenue of $226m beat guidance for $220-225m, with UEBITDA of $56.2m also ahead of $54-56m guidance. Given industry volume contracted ~3% in 2H25, this was a solid result.

Looking to FY 2026, the broker highlights that Propel had a record month in July. And while no guidance has been given for the year ahead, Macquarie is feeling confident. Especially given the prospect of earnings accretive acquisitions. It adds:

FY26 off to a good start. Jul'25 revenue was a record month, exceeding $21.5m. This reflected 1) seasonally stronger funeral volume; 2) ARPF growth of +2.7% YoY; and 3) contributions from acquisitions. PFP has not provided quantitative FY26 guidance, however we expect 1) organic death volume should return to ABS/StatsNZ forecast trends (+2-3% pa); and 2) ARPF growth should be broadly in line with inflation (+2-4% pa). Upside likely exists to our forecasts from potential acquisitions.

Time to buy

According to the note, Macquarie has retained its outperform rating on the ASX All Ords stock with an improved price target of $5.80 (from $5.66).

Based on its current share price of $5.05, this implies potential upside of 15% for investors over the next 12 months.

But the returns won't stop there. The broker expects dividend yields of 2.8% in FY 2026 and then 3.1% in FY 2027. This boosts the total potential 12-month return to approximately 18%.

Commenting on its recommendation, Macquarie said:

Retain outperform. Long-term fundamentals remain attractive, with M&A continuing to represent material earnings upside.

Valuation: TP +2.5% to $5.80 ($5.66 prior) as minor earnings cuts offset by 1) val roll fwd; and 2) moving to the mid-point of our 14-16x NTM EV/ EBITDA range. We value PFP on a 50:50 blended DCF and 16x NTM EV/ EBITDA multiple.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX share tips from 4 brokers, for returns better than 40%

These shares are ripe for a re-rating the analysts say.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

2 ASX mining shares to sell: experts

Experts say it's time to sell these ASX mining shares after an impressive run in FY26.

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Broker Notes

Buy, hold, sell: Weebit Nano, Metals X, Pro Medicus shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Young boy with glasses in a suit sits at a chair and reads a newspaper.
Broker Notes

Sell Judo shares and 2 other ASX small caps: experts

ASX small-cap shares outperformed the broader market in FY26, but experts are calling time on these 3 stocks. Here's why.

Read more »

A young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Broker Notes

Buy, hold, sell: SKS Technologies, Yancoal, Wesfarmers shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Wisetech Global, CBA shares

Experts explain their ratings on 3 ASX 200 shares. 

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Broker Notes

Up 149% in a year, why this surging ASX 300 tech stock is still a good buy today

One expert weighs in.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Up 75%, are Pro Medicus shares still a good buy now?

A leading analyst provides his forecast for Pro Medicus shares.

Read more »